Complement Factor P Quantitative ELISA

$882.00
Catalog
13-COMPL-FPQ
The Complement Factor P Quantitative ELISA is for the quantitative determination of the function of Factor P in human serum or EDTA plasma. For Research Use Only. Not for Use in Diagnostic Procedures.
Species
Human
Regulatory Status
Research Use Only. Not for Use in Diagnostic Procedures.
Product Distribution
Available in North America Only
Range
0-200 ng/ml
Sensitivity
12.5 ng/ml
Sizes
96 Wells
Sample Types
EDTA Plasma, Serum
Inc Time Hour
2 hr
Inc Time Overnight
No
Inc Time See Protocol
No
Sample Size
100
Detection
Colorimetric
The Factor P Quantitative Assay is a sandwich ELISA for quantifying human Factor P in serum or EDTA plasma. The assay is based on immobilized antibody in a 96-well plate, which captures Factor P present in samples incubated in the plates. The bound Factor P is detected with a secondary antibody labelled with HRP. The HRP subsequently catalyzes a cleavage of the substrate that induces a color change correlating with the concentration of Factor P in the sample. Factor P (Complement P, Properdin, FP) is a positive regulator and an initiator of the alternative pathway (AP) for complement activation. It binds surface-bound C3 and C5 convertases and stabilizes them to amplify the activation cascade1. Factor P binding increases the half-life of the convertase complex approximately 10-fold2. It is suggested, however debated, that Factor P also can initiate complement activation by binding for example cell surfaces or certain biological substrates, recruiting C3b or C3(H2O) and Factor B and thus initiate the AP pathway1,3. Factor P opposes the negative regulation of Factor H that enhances the dissociation of C3b and Bb and mediates Factor I cleavage of C3b to the inactive iC3b3. Please see instructions for use for more information.

Complement Factor P Quantitative ELISA

13-COMPL-FPQ

Billing Address

Shipping Address

Resources to advance your discoveries 

Recent posts

8 Questions to Ask Before Choosing an Allergy Testing Platform
8 Questions to Ask Before Choosing an Allergy Testing Platform
1. What percentage of your IgE allergy testing panel consists of molecular allergens rather than allergen extracts? The ALEX2 IgE allergen panel consists of 117 extracts and 183 molecular allergens. This represents the largest panel of molecular allergens on the market, including 50 unique...
View Now
Understanding IgE Allergy Test Results
Understanding IgE Allergy Test Results
Cases of food and environmental allergies have been increasing over the last decade. While conservative estimates suggest IgE-mediated allergy affects 6-8% of children and 2-3% of adults, some estimates are as high as 30%.3, 2 Symptoms can range from mild to severe and include itching, hives,...
View Now
Improving Food Elimination Diets with IgG Testing
Improving Food Elimination Diets with IgG Testing
Food sensitivity or food intolerance involves a non-allergic response to a food or food additive. In a recent on-line survey conducted in the U.S., 24% of adults aged 18 to 79 reported a food intolerance. While a food allergy is typically mediated by IgE antibodies, adverse reactions to food...
View Now

Recent posts

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings
Salem, NH, December 19, 2023 – Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership to enhance the availability of GeneProof PCR kits throughout the...
View Now
Targeted Solutions for Gastroenterology
Targeted Solutions for Gastroenterology
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
View Now
 Optimizing IBD Management with Fecal Calprotectin: From Diagnosis to Monitoring
Live Webinar: Optimizing IBD Management with Fecal Calprotectin - From Diagnosis to Monitoring
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
View Now

Biomarkers of Energy Homeostasis Brochure

Energy homeostasis is a focus of research into diabetes and obesity. Read about how our assays in this area can assist both academic and industry researchers.

Complement System Solutions for Drug Development and Clinical Research Datasheet

The complement system is essential to innate immunity from a variety of diseases. ALPCO’s full range of complement system immunoassays can drive discovery.

Melatonin Products for Sleep Disorder-Related Research Datasheet

The melatonin hormone affects the circadian rhythm and sleep-wake cycle. Find out about our immunoassays and products that explore melatonin and sleep disorders.